NRX PRO

Serial Number 98406494
688

Registration Progress

Application Filed
Feb 15, 2024
Under Examination
Jan 7, 2025
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered

Basic Information

Serial Number
98406494
Filing Date
February 15, 2024
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jan 7, 2025
Application
Pending
Classes
005

Rights Holder

Sumrall, Andrew

01
Address
61300 Ironwood Road
South Bend, IN 46614

Ownership History

Sumrall, Andrew

Original Applicant
01
South Bend, IN

Sumrall, Andrew

Owner at Publication
01
South Bend, IN

Legal Representation

Attorney
Louis T. Perry

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

20 events
Date Code Type Description
Jun 3, 2025 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 7, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Oct 28, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED
Oct 28, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 28, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
Sep 17, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Sep 17, 2024 ALIE A ASSIGNED TO LIE
Sep 16, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED
Sep 16, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
Sep 16, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 3, 2024 DOCK D ASSIGNED TO EXAMINER
Sep 3, 2024 DOCK D ASSIGNED TO EXAMINER
Sep 3, 2024 DOCK D ASSIGNED TO EXAMINER
Jun 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
dietary supplement to help reduce cellular injury and combat chronic inflammation

Additional Information

Pseudo Mark
NRX PRO NAD PLUS CELLULAR THERAPY
Pseudo Mark
NRX PRO NAD AND CELLULAR THERAPY

Classification

International Classes
005